Clinical Study
Risk Factors and Prognostic Significance of Retropancreatic Lymph Nodes in Gastric Adenocarcinoma
Table 1
Comparison of clinicopathological characteristics and pathological stage of number 13 LNs (+) and number 13 LNs (−) groups.
| | | Characteristics | Number 13 LNs (+) | Number 13 LNs (−) | value | | | = 26 (%) | = 88 (%) |
| | Age | Mean ± SD | 56.7 ± 9.9 | 55.6 ± 12.6 | 0.685 | | ≥60 yrs | 12 (46.2) | 35 (39.8) | | <60 yrs | 14 (53.8) | 53 (60.2) |
| | Gender | Male | 21 (80.8) | 58 (65.9) | 0.149 | | Female | 5 (19.2) | 30 (34.1) |
| | Longitudinal location | U | 5 (19.2) | 10 (11.4) | 0.560 | | M | 4 (15.4) | 17 (19.3) | | L | 17 (65.4) | 61 (69.3) |
| | Differentiation grade | Well/moderate | 0 (0) | 17 (19.3) | 0.011 | | Poor/undifferentiated | 26 (100) | 71 (80.7) |
| | Macroscopic type | Types 0–2 | 8 (30.8) | 49 (55.7) | 0.026 | | Types 3–4 | 18 (69.2) | 39 (44.3) |
| | Tumor size | Mean ± SD | 6.1 ± 2.2 | 5.1 ± 3.2 | 0.015 | | ≤2 cm | 1 (3.8) | 10 (11.4) | | 2–5 cm | 9 (34.6) | 49 (55.7) | | 5–8 cm | 14 (53.8) | 19 (21.5) | | >8 cm | 2 (7.8) | 10 (11.4) |
| | Adjacent structures invasion | No | 18 (69.2) | 84 (95.6) | <0.001 | | Spleen | 1 (3.8) | 1 (1.1) | | Liver | 0 (0) | 1 (1.1) | | Pancreas | 7 (27.0) | 1 (1.1) | | Transverse colon | 0 (0) | 1 (1.1) |
| | Duodenum invasion | Positive | 3 (11.5) | 4 (4.5) | 0.194 | | Negative | 23 (88.5) | 84 (95.5) |
| | T stage | T1 | 1 (3.8) | 14 (15.7) | <0.001 | | T2 | 0 (0) | 13 (15.7) | | T3 | 17 (65.4) | 58 (65.2) | | T4 | 8 (30.8) | 3 (3.4) |
| | N stage | N0 | 0 (0) | 26 (29.2) | <0.001 | | N1 | 0 (0) | 11 (13.5) | | N2 | 8 (30.8) | 25 (28.1) | | N3 | 18 (69.2) | 26 (29.2) |
| | M stage | M0 | 15 (57.7) | 79 (89.9) | <0.001 | | M1 | 11 (42.3) | 9 (10.1) |
| | TNM stage | I | 0 (0) | 14 (15.7) | <0.001 | | II | 1 (3.8) | 19 (22.5) | | III | 14 (53.8) | 46 (51.7) | | IV | 11 (42.4) | 9 (10.1) |
|
|
LNs: lymph nodes.
SD: standard deviation.
|
